Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / Class 'A' Ordinary Shares
-
Shares outstanding
-
385,837,333
-
Total 13F shares
-
15,728,720
-
Share change
-
-32,294
-
Total reported value
-
$93,738,571
-
Price per share
-
$5.96
-
Number of holders
-
62
-
Value change
-
-$476,505
-
Number of buys
-
26
-
Number of sells
-
32
Institutional Holders of Trinity Biotech plc - Class 'A' Ordinary Shares (TRIB) as of Q1 2017
As of 31 Mar 2017,
Trinity Biotech plc - Class 'A' Ordinary Shares (TRIB) was held by
62 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
15,728,720 shares.
The largest 10 holders included
Paradice Investment Management LLC, HEARTLAND ADVISORS INC, JANUS CAPITAL MANAGEMENT LLC, Boston Partners, Lapides Asset Management, LLC, FIRST WILSHIRE SECURITIES MANAGEMENT INC, 22NW, LP, STONEHILL CAPITAL MANAGEMENT LLC, Senvest Management, LLC, and HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC.
This page lists
62
institutional shareholders reporting positions in this security
for the Q1 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.